Free delivery on orders of 500 zł or more in Poland Products with HPLC quality certificates Dispatched within 24 hours Free delivery on orders of 500 zł or more in Poland Products with HPLC quality certificates Dispatched within 24 hours

Triple G 8 mg

Pudełko peptydu Retatrutyd 8 mg jako odczynnik chemiczny do zastosowań laboratoyjnych

Delivery time

1-2 working days

quality assurance

Chemical reagent

CAS: 2381089-83-2 

4.8/5.00 - 587 opinions
Rating: 4.6 out of 5

Price: 649,99 449.00 00zł

-10% for a second product
-20% for the fourth product

TEMPORARY SHORTAGE OF GOODS

Triple G 8 mg – product information

Triple G 8 mg is a synthetic peptide compound for research applications, designed to analyse complex metabolic pathways involved in incretin signalling, energy balance and regulation of glucose metabolism. From a chemical perspective, the molecule is identified in the literature as retatrutide (LY3437943), a peptide with a triple receptor profile towards GIP, GLP-1 and the glucagon receptor (GCGR). This functional arrangement distinguishes Triple G 8 mg from classical single GLP-1 receptor agonists and from compounds acting exclusively in the GLP-1/GIP system. Thus, Triple G 8 mg can be described as an advanced research reagent for laboratory analyses requiring the assessment of multi-receptor metabolic signalling.

In the scientific literature, Triple G 8 mg, chemically designated as retatrutide, is described primarily in relation to the simultaneous activation of GIP, GLP-1 and GCGR receptors. Under research conditions, activation of GLP-1 and GIP receptors has been linked to modulation of glucose-dependent insulinotropic responses, regulation of glucagon secretion and effects on incretin signalling related to control of energy intake. In turn, glucagon receptor involvement is analysed in terms of energy expenditure, lipid metabolism and overall metabolic balance. This receptor profile underpins the relevance of Triple G 8 mg in metabolic and endocrinological studies.

See also Triple G 20 mg reagent


Triple G 8 mg - research profile

The effect of Triple G 8 mg on selected metabolic parameters, glucose metabolism and mechanisms relating to energy balance also remains an important area of interest. In reviews and clinical trials concerning the molecule chemically identified as retatrutide, its significance in the context of obesity, type 2 diabetes and broader metabolic disorders has been analysed; however, in the laboratory product description, this information is best presented as literature data and research directions, rather than as declared product effects. For this reason, Triple G 8 mg may be presented as a reference reagent for research, comparative and laboratory analyses concerning multi-receptor peptide signalling.Triple G 20 mg Retatrutide is a research reagent in the category of products also searched for as Triple G Endogenic and Triple G Biolab.

From a laboratory characterisation perspective, the main research advantages of Triple G 8 mg include its complex receptor profile, its strong grounding in modern metabolic literature and its ability to simultaneously analyse three key pathways: GLP-1, GIP and GCGR. In the technical documentation and scientific literature, the molecule appears as retatriptide, while in the laboratory product description it can safely be presented as Triple G 8 mg reagent vial, intended for research, comparative and reference analyses only.


Sources:

https://pmc.ncbi.nlm.nih.gov/articles/PMC10844714/

https://pmc.ncbi.nlm.nih.gov/articles/PMC12190491/Retatrutyd 8mg | Triple G 8mg - to odczynnik badawczy z kategorii produktów wyszukiwanych również jako Triple G Endogenic oraz Triple G Biolab.

The product is intended for scientific research and laboratory analysis. All articles and information on this website are for informational and educational purposes only.

Preview of quality studies

Download the safety data sheet

Download instructions for use

ParameterValue
Product nameTriple G 8 mg vial
Catalogue number3862749-08-05
CAS number2381089-83-2
BrandNovell
CategoryTest compound/chemical reagent
Molecular targetGLP-1 / GIP / GCGR receptors
Sequencemodified research peptide; sequence as per batch specification / COA
Summary formulaC221H342N46O68
Molar massapprox. 4731.33 g/mol
Cleanliness≥99% HPLC / according to batch COA
Confirmation of identityMS mass spectrometry / HPLC analysis / batch COA
Forma clear solution in a vial
Unit quantityEach vial contains 8 mg of the test compound. Quantity adapted for multiple laboratory tests and comparative analyses.
Concentrationaccording to batch / COA specifications
Buffer/Carrierlaboratory solution / carrier in accordance with the batch specification
pH of the solutionin accordance with the batch COA
Storage conditionsStore in a cool, dry, and dark place. Once opened, keep in the fridge and protect from light.
Stability after openingaccording to laboratory protocol/batch COA
COA per batchcertificate of analysis available for each batch of product
Applicationexclusively for laboratory tests, reference analyses and research-grade applications
Important informationThis product is classified as a chemical reagent intended solely for scientific research, laboratory analysis and reference purposes. It is not a medicinal product, a food supplement or a foodstuff. It is not intended for use, administration or consumption by humans or animals, nor for diagnostic or therapeutic purposes. The purchaser is obliged to use the product in accordance with its intended purpose, applicable regulations and relevant laboratory procedures. The seller shall not be liable for the consequences of using the product contrary to its declared purpose, subject to mandatory provisions of law.

14 day return policy

LAboratory quality

Safe shopping

Opinions

Add a review
Novell - odczynniki peptydowe Novell – peptide reagents
Rating*
0/5
* Rating is required
Your review
* Review is required
Name
.
* Name is required
4.9
Based on 262 reviews
5
89
89%
4
9
9%